Terminalia laxiflora
Terminalia laxiflora · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Terminalia laxiflora is a fascinating plant species that holds significant potential in the field of natural pharmacology. Researchers have focused extensively on the chemical profile of its leaves to uncover their biological benefits. Through the preparation of various extracts, scientists have been able to isolate key bioactive compounds. These studies have specifically highlighted the potent antioxidant activities present within the plant material. Consequently, this species serves as a promising subject for developing new natural therapeutic agents.
- Synonyms
- Terminalia Elliotii · Terminalia Sokodensis · 4 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Terminalia laxiflora is a distinctive plant species known by various regional designations. In certain linguistic contexts, it is commonly referred to by the name 疏花榄仁. Another widely recognized common name for this species is 疏花欖仁, reflecting subtle variations in character usage. These names serve as important identifiers for botanists and locals alike when discussing the plant's characteristics. Understanding these different nomenclature relationships is essential for accurate botanical identification and study.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia laxiflora is a complex botanical subject that is frequently identified by various taxonomic synonyms in scientific literature. Researchers often encounter this species under the name Terminalia elliotii or the specific variation Terminalia laxiflora var. pubescens. Depending on the regional classification used, it may also be referred to as Terminalia repanda or Terminalia roseogrisea. Furthermore, the name Terminalia schweinfurthii is sometimes employed to describe specimens within this group. Understanding these overlapping designations is essential for maintaining accuracy in botanical studies and plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia laxiflora belongs to the diverse kingdom Plantae, serving as a fascinating subject within the botanical world. As a member of the class Equisetopsida, this species exhibits specialized characteristics typical of its evolutionary lineage. It is further classified under the order Myrtales, which helps scientists understand its broader biological connections. Within this framework, the plant is placed in the family Combretaceae, a group known for its distinct structural traits. Ultimately, its identity is defined by its placement within the genus Terminalia, marking its unique position in nature.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia laxiflora is a resilient species with a widespread distribution spanning several key regions across the African continent. Its presence is notably felt in East Tropical Africa, specifically within the borders of Uganda. Moving toward the northeast, the plant thrives in the diverse landscapes of Chad, Ethiopia, and the Sudan-South Sudan borderlands. The species also extends its reach into West Tropical Africa, where it can be found in Benin. This broad geographic range highlights the plant's ability to adapt to various tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia laxiflora is a self-supporting tree that maintains a sturdy and independent growth form. This species typically reaches a maximum height of approximately 10.97 meters. Its structural characteristics make it a distinct component of its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia laxiflora is recognized for its significant biological potential within the diverse genus of medicinal plants. Scientific investigations into its bark extracts have revealed a notable antioxidant activity, which contributes to its ethnopharmacological value. Specifically, the species demonstrated a strong ability to inhibit DPPH at relatively low concentrations. This antioxidant capacity is supported by a rich phytochemical composition, including essential phenolic compounds. Such findings highlight the plant's importance as a natural source of bioactive molecules for medicinal applications.
Compounds
Conditions
Terminalia laxiflora exhibits significant medicinal potential due to its ability to treat various health concerns. Research indicates that methanolic extracts of its wood are highly potent in treating P. gingivalis bacteria, which is a primary cause of periodontal disease. Additionally, the plant shows effective inhibitory activity against MMP-9, an enzyme that contributes to the destruction of periodontal tissue. Beyond oral health, T. laxiflora is a culturally important species used by Oromo women in traditional cosmetics. It is specifically cited as a frequently used plant for skin treatment through topical application.
Preparations
Terminalia laxiflora is prepared as extracts to evaluate its ethnopharmacological potential and biological activity. These preparations include hydroethanolic, ethanolic, and hexane extracts derived from the bark of the plant. Through this extraction process, the plant demonstrates significant antioxidant properties, specifically showing 50% inhibition of DPPH. The resulting extracts are studied for their ability to inhibit the growth of various bacteria and fungi. Such preparations serve as a key focus for understanding how this species can be utilized in medicinal therapies.
Parts used
Terminalia laxiflora serves as a significant host for various endophytic fungi, which can be a rich source of novel bioactive compounds. In recent studies, researchers specifically focused on the leaves of this plant to isolate the fungus Curvularia sp. Through the use of advanced metabolomic tools, the chemical fingerprints of fungal extracts derived from these leaves were meticulously compared. This process allowed scientists to identify specific metabolites that exhibit potential bioactivity against leukemia cell lines. Ultimately, the investigation of the plant's foliage has successfully led to the isolation of unique peptides and natural products.